Swiss drugs regulator approves first bivalent COVID-19 booster

Vials labelled COVID-19 Coronavirus Vaccine are placed on dry ice in this illustration taken, December 5, 2020. Image used for illustrative purpose only. Dado Ruvic/Illustration, Reuters
Reuters Images

Moderna's Spikevax vaccine, which contains mRNA against two coronavirus variants

Staff Writer, Reuters News

August 29, 2022

PHOTO
Vials labelled COVID-19 Coronavirus Vaccine are placed on dry ice in this illustration taken, December 5, 2020. Image used for illustrative purpose only. Dado Ruvic/Illustration, Reuters

Swiss drugs regulator Swissmedic said on Monday that it has approved the first bivalent Covid-19 booster vaccine in the country. Moderna's Spikevax vaccine, which contains mRNA against two coronavirus variants, is authorized for anyone 18 years or older, said Swissmedic. (Writing by Miranda Murray; Editing by Maria Sheahan)

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO